MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Investment Ideas Pro

Has Abbott Laboratories Just Redefined Its Future with Exact Sciences

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Does UBS O'Connor's Big Bet on Exact Sciences Really Mean

3 months ago

Has Dolby Laboratories Found Its Groove in Q2 2026

1 months ago

Has Alumis's Envudeucitinib Redefined Psoriasis Treatment

2 months ago

Is Kraig Biocraft Laboratories on the Cusp of a Material Revolution

2 months ago

Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors

Abbott (ABT) fell 1.64% to $88.18 in the most recent session, underperforming a broader market improvement.

ABT

Stock News•6 days ago

Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story

Abbott's cancer diagnostics growth prospects strengthened by its Exact Sciences acquisition, supported by new data and updated screening guidelines.

ABT

Stock News•1 months ago

A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried?

AbbVie’s Skyrizi, a key growth driver, faces potential competitive pressure from a new, experimental drug. Early data suggests the rival treatment may offer superior efficacy, threatening the $17B rev...

ABBV

Stock News•1 months ago

This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy?

Abbott Laboratories' dividend yield is approaching 3%, marking its highest level in a decade. The healthcare giant maintains its status as a Dividend King with over 50 consecutive years of payout incr...

ABT